Ustekinumab as Induction and Maintenance Therapy for Crohn’s DiseaseBrian G. Feagan, Paul Rutgeerts, Miao Ye et al.|New England Journal of Medicine|2016Cited by 1.8k
Fistula Healing in Pivotal Studies of Ustekinumab in Crohn's DiseaseBruce E. Sands, William J. Sandborn, Christopher Gasink et al.|Gastroenterology|2017Cited by 82
768 A Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Ustekinumab Maintenance Therapy in Moderate - Severe Crohn's Disease Patients: Results From IM-UNITIWilliam J. Sandborn, Paul Rutgeerts, Brian G. Feagan et al.|Gastroenterology|2016Cited by 14
Long-Term Efficacy and Safety of Ustekinumab for Crohn’s Disease: Results From Im-Uniti Long-Term Extension Through two YearsWilliam J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al.|Gastroenterology|2017Cited by 6